Spector Roseman & Kodroff, P.C. was recently appointed Lead Counsel in a securities fraud class action against MEDNAX, Inc., pending in the United States District Court for the Southern District of Florida. MEDNAX is a healthcare administration company that acquires and administers physician practice groups. The action alleges that, between February 4, 2016 and July 27, 2017, MEDNAX defrauded investors by falsely claiming that it had a robust pipeline of new acquisitions. In fact, the Company’s pipeline was languishing as the number of new acquisitions waned. When this information became public, the price of MEDNAX stock declined precipitously and investors suffered significant damages. SRK is preparing an amended complaint against MEDNAX, which will detail the legal basis for defrauded investors to recover their losses.